Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Eagle Pharmaceuticals, Inc. to Present at Jefferies 2017 London Healthcare Conference

Eagle Pharmaceuticals,Inc.
Posted on: 07 Nov 17

Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, will present at the Jefferies 2017 London Healthcare Conferences as follows:

Date: Wednesday, November 15, 2017
Time: 8:00 a.m. Greenwich Mean Time
Location: The Waldorf Hilton, Aldwych, London, UK



The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at

View source version on

Business Wire

Last updated on: 07/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.